138 related articles for article (PubMed ID: 17976740)
1. Decreased cerebrospinal fluid concentrations of substance P in treatment-resistant depression and lack of alteration after acute adjunct vagus nerve stimulation therapy.
Carpenter LL; Bayat L; Moreno F; Kling MA; Price LH; Tyrka AR; Kinkead B; Owens MJ; Nemeroff CB
Psychiatry Res; 2008 Jan; 157(1-3):123-9. PubMed ID: 17976740
[TBL] [Abstract][Full Text] [Related]
2. Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients.
Carpenter LL; Moreno FA; Kling MA; Anderson GM; Regenold WT; Labiner DM; Price LH
Biol Psychiatry; 2004 Sep; 56(6):418-26. PubMed ID: 15364040
[TBL] [Abstract][Full Text] [Related]
3. Substance P in serum and cerebrospinal fluid of depressed patients: no effect of antidepressant treatment.
Deuschle M; Sander P; Herpfer I; Fiebich BL; Heuser I; Lieb K
Psychiatry Res; 2005 Jul; 136(1):1-6. PubMed ID: 16024091
[TBL] [Abstract][Full Text] [Related]
4. Vagus nerve stimulation for depression: efficacy and safety in a European study.
Schlaepfer TE; Frick C; Zobel A; Maier W; Heuser I; Bajbouj M; O'Keane V; Corcoran C; Adolfsson R; Trimble M; Rau H; Hoff HJ; Padberg F; Müller-Siecheneder F; Audenaert K; Van den Abbeele D; Stanga Z; Hasdemir M
Psychol Med; 2008 May; 38(5):651-61. PubMed ID: 18177525
[TBL] [Abstract][Full Text] [Related]
5. A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression.
George MS; Rush AJ; Marangell LB; Sackeim HA; Brannan SK; Davis SM; Howland R; Kling MA; Moreno F; Rittberg B; Dunner D; Schwartz T; Carpenter L; Burke M; Ninan P; Goodnick P
Biol Psychiatry; 2005 Sep; 58(5):364-73. PubMed ID: 16139582
[TBL] [Abstract][Full Text] [Related]
6. Clinical issues in considering vagus nerve stimulation for treatment-resistant depression.
Rush AJ; Siefert SE
Exp Neurol; 2009 Sep; 219(1):36-43. PubMed ID: 19397908
[TBL] [Abstract][Full Text] [Related]
7. Vagus nerve stimulation and deep brain stimulation for treatment resistant depression.
Carpenter LL; Friehs GM; Tyrka AR; Rasmussen S; Price LH; Greenberg BD
Med Health R I; 2006 Apr; 89(4):137, 140-1. PubMed ID: 16676910
[TBL] [Abstract][Full Text] [Related]
8. Concomitant use of vagus nerve stimulation and electroconvulsive therapy for treatment-resistant depression.
Burke MJ; Husain MM
J ECT; 2006 Sep; 22(3):218-22. PubMed ID: 16957540
[TBL] [Abstract][Full Text] [Related]
9. P300 is enhanced in responders to vagus nerve stimulation for treatment of major depressive disorder.
Neuhaus AH; Luborzewski A; Rentzsch J; Brakemeier EL; Opgen-Rhein C; Gallinat J; Bajbouj M
J Affect Disord; 2007 Jun; 100(1-3):123-8. PubMed ID: 17098290
[TBL] [Abstract][Full Text] [Related]
10. Combined VNS-rTMS treatment in a patient with therapy resistant depression.
Sperling W; Kornhuber J; Wiltfang J; Bleich S
Pharmacopsychiatry; 2007 Jan; 40(1):39-40. PubMed ID: 17327961
[No Abstract] [Full Text] [Related]
11. Vagus nerve stimulation acutely alters food craving in adults with depression.
Bodenlos JS; Kose S; Borckardt JJ; Nahas Z; Shaw D; O'Neil PM; George MS
Appetite; 2007 Mar; 48(2):145-53. PubMed ID: 17081655
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal neuropeptide Y and substance P in suicide attempters during long-term antidepressant treatment.
Olsson A; Regnéll G; Träskman-Bendz L; Ekman R; Westrin A
Eur Neuropsychopharmacol; 2004 Dec; 14(6):479-85. PubMed ID: 15589387
[TBL] [Abstract][Full Text] [Related]
13. CSF serotonin, 5-hydroxyindolacetic acid and neuropeptide Y levels in severe major depressive disorder.
Hou C; Jia F; Liu Y; Li L
Brain Res; 2006 Jun; 1095(1):154-8. PubMed ID: 16713589
[TBL] [Abstract][Full Text] [Related]
14. Treatment resistant depression--advances in somatic therapies.
Kennedy SH; Giacobbe P
Ann Clin Psychiatry; 2007; 19(4):279-87. PubMed ID: 18058285
[TBL] [Abstract][Full Text] [Related]
15. Neurostimulation therapies in depression: a review of new modalities.
Marangell LB; Martinez M; Jurdi RA; Zboyan H
Acta Psychiatr Scand; 2007 Sep; 116(3):174-81. PubMed ID: 17655558
[TBL] [Abstract][Full Text] [Related]
16. Vagus nerve stimulation: 2-year outcomes for bipolar versus unipolar treatment-resistant depression.
Nierenberg AA; Alpert JE; Gardner-Schuster EE; Seay S; Mischoulon D
Biol Psychiatry; 2008 Sep; 64(6):455-60. PubMed ID: 18571625
[TBL] [Abstract][Full Text] [Related]
17. Neurostimulation in resistant depression.
Carpenter LL
J Psychopharmacol; 2006 May; 20(3 Suppl):35-40. PubMed ID: 16644770
[TBL] [Abstract][Full Text] [Related]
18. Cardiac rhythm disturbance in a depressed patient after implantation with a vagus nerve stimulator.
Singleton AH; Rosenquist PB; Kimball J; McCall WV
J ECT; 2009 Sep; 25(3):195-7. PubMed ID: 19384253
[TBL] [Abstract][Full Text] [Related]
19. Changes in gustatory perceptions of patients with major depression treated with vagus nerve stimulation (VNS).
Sperling W; Biermann T; Spannenberger R; Clepce M; Padberg F; Reulbach U; Kornhuber J; Thuerauf N
Pharmacopsychiatry; 2011 Mar; 44(2):67-71. PubMed ID: 21157695
[TBL] [Abstract][Full Text] [Related]
20. Elevated cerebrospinal fluid substance p concentrations in posttraumatic stress disorder and major depression.
Geracioti TD; Carpenter LL; Owens MJ; Baker DG; Ekhator NN; Horn PS; Strawn JR; Sanacora G; Kinkead B; Price LH; Nemeroff CB
Am J Psychiatry; 2006 Apr; 163(4):637-43. PubMed ID: 16585438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
